Keybanc reiterated coverage of Inovalon Holdings with a rating of Overweight and set a new price target of $40.00 from $35.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/25/2021 | Overweight → Sector Weight | Keybanc | |
| 8/20/2021 | Buy → Neutral | BTIG | |
| 7/29/2021 | $35.00 → $40.00 | Overweight | Keybanc |
| 7/28/2021 | $35.00 → $45.00 | Outperform | SVB Leerink |
Keybanc downgraded Inovalon Holdings from Overweight to Sector Weight
BTIG downgraded Inovalon Holdings from Buy to Neutral
Keybanc reiterated coverage of Inovalon Holdings with a rating of Overweight and set a new price target of $40.00 from $35.00 previously
15-12B - Inovalon Holdings, Inc. (0001619954) (Filer)
S-8 POS - Inovalon Holdings, Inc. (0001619954) (Filer)
S-8 POS - Inovalon Holdings, Inc. (0001619954) (Filer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
4 - Inovalon Holdings, Inc. (0001619954) (Issuer)
BOWIE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the completion of its acquisition by an equity consortium led by Nordic Capital, and joined by Insight Partners, as lead co-investor, 22C Capital, and Inovalon founder and chief executive officer Keith Dunleavy, M.D. and certain Class B stockholders of Inovalon. The acquisition was previously announced on August 19, 2021, and was approved by Inovalon's stockholders on November 16, 2021. In accordance with the terms of the agreement, Inovalon stockholders will receive $41.00 in cash for each share of Class A Common Stock and Cla
BOWIE, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual ScriptMed® Conference will take place virtually from November 8-9, 2021. This prestigious two-day event features the industry's leading executives and thought leaders discussing the ways in which technology can enable collaborative partnerships to facilitate data sharing and empower patients and their providers. A panel of prominent specialty pharmacy experts from AllianceRx Walgreens Prime, AIDS Healthcare Foundation, and Perigon Pharmacy will open the ScriptMed® Conference, sharing their thoughts and futuristic vie
Former CMS Administrator Seema Verma, Snowflake CEO Frank Slootman, and Aetna/CVS Chief Medical Officer Dr. Kyu Rhee to Deliver Keynotes on Data-Driven Healthcare BOWIE, Md., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual Client Congress will take place virtually from October 18-19, 2021. Client Congress builds on a decade of bringing together the nation's most influential voices to address the programs, perspectives, and policies shaping U.S. healthcare and to share insights intended to help organizations thrive in today's dynamic marketplace. This is the second time in thi
BOWIE, Md., June 28, 2021 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the appointment of Eron S. Kelly as its Corporate President. Mr. Kelly brings more than 20 years of experience in global software and cloud-based technology growth as a seasoned executive leader at Amazon and Microsoft. As Inovalon's Corporate President, Mr. Kelly will be responsible for the management, operation, and results of the Company's multiple business units, their respective growth, product offerings, value achievement, and performance, as well as related support of customer and strategic relationships, total cust
Second Quarter 2021 Highlights Q2 revenue of $190.4 million, up 17% YoY and 8% sequentiallyQ2 subscription-based platform revenue of $168.7 million, up 19% YoY and 7% sequentially, equating to 89% of Q2 total revenueQ2 net income of $9.6 million, resulting in diluted net income of $0.06 per shareQ2 Non-GAAP net income of $27.9 million, resulting in Non-GAAP net income of $0.19 per share, up 27% YoYQ2 Adjusted EBITDA of $64.1 million, up 13% YoY and 9% sequentially, resulting in adjusted EBITDA margin of 33.7%Q2 new sales Annual Contract Value (ACV)1 totaled $60.5 million and platform new sales ACV totaled $43.2 million Debt & Cash Highlights Cash balance as of June 30, 2021 totaling $117.
SC 13G/A - Inovalon Holdings, Inc. (0001619954) (Subject)
SC 13G/A - Inovalon Holdings, Inc. (0001619954) (Subject)
SC 13G/A - Inovalon Holdings, Inc. (0001619954) (Subject)